[Retracted] Psorinum Therapy in Treating Stomach, Gall Bladder, Pancreatic, and Liver Cancers: A Prospective Clinical Study

Table 3

Survival outcomes in each cancer type.

Primary organ affected	No. of Patients	Male	Female	Survived at least 1 year	Survived at least 2 years	Survived at least 3 years	Survived at least 4 years	Survived at least 5 years
Stomach	42	22	20	34	24	21	20	16 (38.1%)
G. Bladder	40	21	19	32	25	20	18	15 (37.5%)
Pancreas	44	24	20	34	28	27	21	17 (38.64%)
Liver	32	17	15	26	22	19	17	14 (43.75%)